Rheumnow Podcast - podcast cover

Rheumnow Podcast

Dr. Cush•rheumnow.podbean.com
Health & Fitness
Medicine
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Last refreshed: ⓘ
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Follow on
Apple Podcasts
Spotify
RSS
YouTube
Overcast
Pocket Casts
Episodes.fm
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

QD Clinics 157-160 Lessons from the Clinic

QD157 Steroid Weaning QD158 Diagnosing Neuropsychiatric Lupus QD159 - Not the Same Ol’ Lecture QD160 - Your Next Follow-up Visit is When?

Feb 11, 2022•33 min•Ep. 871

Hand OA and Heroes in Rheumatology (2.11.2022)

Dr. Jack Cush reviews the news and journal articles from this past week in RheumNow.com. Interesting reports this week about dementia, who gets hand OA and a great list of women Heroes and Pillars of Rheumatology.

Feb 11, 2022•19 min•Ep. 870

An Ounce of Prevention (2.4.2022)

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. He discusses the GI side effects of IL-17 inhibitors, downstream revenues from rheumatology care and dietary prevention of gout.

Feb 04, 2022•27 min•Ep. 869

Believing is Doing (1.21.2022)

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. These reports are about better outcomes in Lupus; Less Gout flares with T2T and the power of belief.

Jan 21, 2022•28 min•Ep. 867

The Overpricing of Drugs (1.14.2022)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com RheumNow.Live is March 19, 20th in Dallas, TX

Jan 14, 2022•27 min•Ep. 866

Best of 2021 -Jack of All Subspecialties (12.31.2021)

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections during f...

Dec 31, 2021•28 min•Ep. 863

My Podcast Gift (12.24.2021)

Merry Christmas and Happy Holidays from RheumNow. Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to get into podcasting - for teaching, practice, fun or influence.

Dec 24, 2021•23 min•Ep. 862

Indications Awaiting (12.17.21)

Dr Jack Cush reviews the latest news, journal reports, regulatory approvals, plus 3 new cases from rheumatologists.

Dec 17, 2021•30 min•Ep. 861

Women Leaders in Rheumatology

A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encountered during the COVID-19 pandemic..

Dec 14, 2021•26 min•Ep. 860

T2T Debate - Prologue with Dr. Marty Bergman

Drs. Jack Cush and Martin Bergman gather to review the topic of treat-to-target (T2T) management in rheumatology. Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022. You can register and learn more about the meeting at: https://r-w-c-s.com/2022/

Dec 10, 2021•26 min•Ep. 857

ACR2021 - Day6a

ALPN-303 - Dr. Pedro Castillo Dr. Castillo reports on abstract #1429 presented at the ACR21 annual meeting.

Nov 13, 2021•10 min•Ep. 852

ACR2021 - Day5b

JAK Safety -- The Lowdown on Infection: Drs. Kevin Winthrop and Jonathan Kay Infections in ORAL Surveillance: Drs. Kevin Winthrop and Jonathan Kay Infliximab Drug Monitoring in PsA, RA, AxSpA: Dr. Pedro Castillo Lupus and Pregnancy: Dr. Sheila Reyes Secukinumab Effect on CV Risks in PsA, axSpA: Dr. Sheila Reyes

Nov 11, 2021•22 min•Ep. 850

ACR2021 - Day5a

Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim Potpourri of Biosimilar Trials: Dr. Jonathan Kay Closing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao

Nov 10, 2021•29 min•Ep. 845

ACR2021 - Day4e

Glucocorticoids and CV risk in RA: Drs. Aurelie Najm and Jon Giles Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay Rheumatic Diseases Can Take your Breath Away: Dr.Janet Pope Best of PsA Day 4 (Tuesday): MACE in PsA: Dr. Rachel Tate Predicting Progression from Psoriasis to PsA: Dr. Robert Chao David Liew Interview Dr. Seoyoung Kim About Tofacitinib and Malignancy Risk. Third Time's the Charm - COVID Vaccination While on Rituximab: Dr. Yuz Yusof Can We Stop Medica...

Nov 10, 2021•48 min•Ep. 840

ACR2021 - Day4d

Diagnosing (Bad) VEXAS: The Experts Speak with Drs. Cush, Beck and Ferrada CV Risks and Gout T2T - An Interview with Dr. Seoyoung Kim, Kathryn Dao

Nov 09, 2021•36 min•Ep. 839
← PrevNext →
For the best experience, listen in Metacast app for iOS or Android